Management of chronic brain syndrome secondary to cerebral arteriosclerosis, with special reference to papaverine hydrochloride.
D000368:Aged; D001007:Anxiety / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy*; D003863:Depression / Q000188:drug therapy; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications*; D008569:Memory Disorders / Q000188:drug therapy; D010208:Papaverine / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos
D010919:Placebos; D010208:Papaverine